...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: For what it’s worth
Reply New Message
Back To Forum List View
For what it’s worth
6
jbuffett62
Jul 19, 2023 10:06AM
Re: For what it’s worth
3
KOO-KOO2
Jul 19, 2023 10:40AM
Re: For what it’s worth
2
tada
Jul 19, 2023 05:11PM
Re: For what it’s worth
2
tada
Jul 19, 2023 05:13PM
Re: For what it’s worth
3
KOO-KOO2
Jul 20, 2023 06:52AM
Re: For what it’s worth
3
jbuffett62
Jul 20, 2023 08:04AM
Re: For what it’s worth
3
Buckeyes
Jul 20, 2023 08:18AM

I'm wondering what the smart money play is here for Zenith:

1.  Outright sale to (ex) Pfizer

2.  Pfizer then controls sales to competitors to aid their combo drugs as several biopharms are going to want this.  Could be MAJOR leverage with billions in dollars of treatment extensions at play  

3.  Keep all rights and sell to each biopharm for combo usage for decades

4 Recommendations
Reply New Message
Back To Forum List View
Share
Share
New Message
Please login to post a reply